Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate the efficacy and safety of TQA3810 tablets in combination with or without nucleoside (acid) analogue therapy for patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TQA3810

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: RECRUITING